CISI FIN (06058) is offering for sale a total of $7 million in notes.
Guotai Junan International (06058) issued an announcement. The company's indirectly wholly-owned subsidiary, CISI Investment...
CISI FIN (06058) announced that its indirect wholly-owned subsidiary, CISI Investment, sold notes with a principal amount totaling $7 million (approximately HK$54.95 million) on the open market on January 3, 2025, and January 9, 2025, for a total consideration of approximately $6.9869 million.
Related Articles
SIHUAN PHARM(00460): Innovative drug Genaton included in the national basic medical insurance drug list for the first time.
Zhejiang Reclaim Construction Group (002586.SZ) jointly won the bid for the related engineering projects of the Jiangsu Nonghua Intelligent Agriculture Technology project in Luoping County.
SIHUAN PHARM (00460): Innovative drug Anjuwei successfully renewed and included in the 2025 National Basic Medical Insurance Drug List.
SIHUAN PHARM(00460): Innovative drug Genaton included in the national basic medical insurance drug list for the first time.
Zhejiang Reclaim Construction Group (002586.SZ) jointly won the bid for the related engineering projects of the Jiangsu Nonghua Intelligent Agriculture Technology project in Luoping County.
SIHUAN PHARM (00460): Innovative drug Anjuwei successfully renewed and included in the 2025 National Basic Medical Insurance Drug List.
